The role of metastasectomy in renal cell carcinoma

Eleni Josephides; Alejo Rodriguez-Vida; Myria Galazi; Simon Chowdhury; Aneta Suder

doi:10.1586/14737140.2013.856762

The role of metastasectomy in renal cell carcinoma

Eleni Josephides, Alejo Rodriguez-Vida, Myria Galazi, Simon Chowdhury^*, Aneta Suder

^*Corresponding author for this work

GSTT Guy's and St Thomas' NHS Foundation Trust

Research output: Contribution to journal › Literature review › peer-review

5 Citations (Scopus)

Abstract

Despite significant advances in the systemic treatment of metastatic renal cell carcinoma, long-term survival remains low. A potential way to improve outcomes in selected cases is the use of metastasectomy, which is part of the multimodal treatment of this disease. Although the evidence supporting this approach is limited, we believe it is a reasonable option for certain patients. This review summarizes the evidence supporting this approach.

Original language	English
Pages (from-to)	1363-1371
Number of pages	9
Journal	EXPERT REVIEW OF ANTICANCER THERAPY
Volume	13
Issue number	12
DOIs	https://doi.org/10.1586/14737140.2013.856762
Publication status	Published - Dec 2013

Keywords

metastasectomy
renal cell carcinoma
targeted therapy
PROSPECTIVE CLINICAL-TRIALS
SINGLE-CENTER EXPERIENCE
LONG-TERM SURVIVAL
PULMONARY METASTASECTOMY
CYTOREDUCTIVE NEPHRECTOMY
PROGNOSTIC-FACTORS
BRAIN METASTASES
STRATIFICATION TOOL
ADRENAL METASTASIS
SURGICAL RESECTION

Access to Document

10.1586/14737140.2013.856762

Cite this

@article{57ea1c80c35945e0a8844709b20ba721,

title = "The role of metastasectomy in renal cell carcinoma",

abstract = "Despite significant advances in the systemic treatment of metastatic renal cell carcinoma, long-term survival remains low. A potential way to improve outcomes in selected cases is the use of metastasectomy, which is part of the multimodal treatment of this disease. Although the evidence supporting this approach is limited, we believe it is a reasonable option for certain patients. This review summarizes the evidence supporting this approach.",

keywords = "metastasectomy, renal cell carcinoma, targeted therapy, PROSPECTIVE CLINICAL-TRIALS, SINGLE-CENTER EXPERIENCE, LONG-TERM SURVIVAL, PULMONARY METASTASECTOMY, CYTOREDUCTIVE NEPHRECTOMY, PROGNOSTIC-FACTORS, BRAIN METASTASES, STRATIFICATION TOOL, ADRENAL METASTASIS, SURGICAL RESECTION",

author = "Eleni Josephides and Alejo Rodriguez-Vida and Myria Galazi and Simon Chowdhury and Aneta Suder",

year = "2013",

month = dec,

doi = "10.1586/14737140.2013.856762",

language = "English",

volume = "13",

pages = "1363--1371",

journal = "EXPERT REVIEW OF ANTICANCER THERAPY",

issn = "1473-7140",

publisher = "Expert Reviews Ltd.",

number = "12",

}

TY - JOUR

T1 - The role of metastasectomy in renal cell carcinoma

AU - Josephides, Eleni

AU - Rodriguez-Vida, Alejo

AU - Galazi, Myria

AU - Chowdhury, Simon

AU - Suder, Aneta

PY - 2013/12

Y1 - 2013/12

N2 - Despite significant advances in the systemic treatment of metastatic renal cell carcinoma, long-term survival remains low. A potential way to improve outcomes in selected cases is the use of metastasectomy, which is part of the multimodal treatment of this disease. Although the evidence supporting this approach is limited, we believe it is a reasonable option for certain patients. This review summarizes the evidence supporting this approach.

AB - Despite significant advances in the systemic treatment of metastatic renal cell carcinoma, long-term survival remains low. A potential way to improve outcomes in selected cases is the use of metastasectomy, which is part of the multimodal treatment of this disease. Although the evidence supporting this approach is limited, we believe it is a reasonable option for certain patients. This review summarizes the evidence supporting this approach.

KW - metastasectomy

KW - renal cell carcinoma

KW - targeted therapy

KW - PROSPECTIVE CLINICAL-TRIALS

KW - SINGLE-CENTER EXPERIENCE

KW - LONG-TERM SURVIVAL

KW - PULMONARY METASTASECTOMY

KW - CYTOREDUCTIVE NEPHRECTOMY

KW - PROGNOSTIC-FACTORS

KW - BRAIN METASTASES

KW - STRATIFICATION TOOL

KW - ADRENAL METASTASIS

KW - SURGICAL RESECTION

U2 - 10.1586/14737140.2013.856762

DO - 10.1586/14737140.2013.856762

M3 - Literature review

SN - 1473-7140

VL - 13

SP - 1363

EP - 1371

JO - EXPERT REVIEW OF ANTICANCER THERAPY

JF - EXPERT REVIEW OF ANTICANCER THERAPY

IS - 12

ER -

The role of metastasectomy in renal cell carcinoma

Abstract

Keywords

Access to Document

Fingerprint

Cite this